Medociprin (Ciprofloxacin Hydrochloride Monohydrate)

Ciprofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By inhibiting these targets, the drug prevents bacterial cell division and leads to bacterial death, providing a bactericidal effect against a wide range of Gram‑negative and some Gram‑positive bacteria.

The dose of Medociprin is individualized by the prescribing healthcare professional based on the type and severity of infection, patient age, renal function, and local susceptibility patterns. No fixed dosing regimen is provided here; clinicians set the appropriate regimen for each patient.

Safety data for ciprofloxacin in pregnancy and lactation are limited, and the drug is generally avoided unless the potential benefit justifies the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Medociprin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Medociprin (ciprofloxacin) belongs to the fluoroquinolone class, offering a broad spectrum of activity similar to levofloxacin. Compared with some other fluoroquinolones, ciprofloxacin has strong activity against Gram‑negative organisms and is often chosen for urinary and gastrointestinal infections, while levofloxacin may have slightly better coverage of certain respiratory pathogens.

Medociprin should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Medociprin is administered orally, typically as a tablet or capsule swallowed with a full glass of water. It should be taken exactly as prescribed, with or without food depending on the specific product instructions, and the full course should be completed even if symptoms improve.

Serious adverse effects include tendon rupture or tendinitis, peripheral neuropathy, Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, and QT interval prolongation. Patients should seek immediate medical attention if they experience sudden tendon pain, numbness, severe diarrhea, rash, or cardiac symptoms.

Medociprin should be avoided in individuals with a known hypersensitivity to ciprofloxacin or other fluoroquinolones, patients with a history of tendon disorders related to fluoroquinolone use, and those with significant cardiac arrhythmias that predispose to QT prolongation. Caution is also advised for patients with severe renal impairment.